TUESDAY, Dec. 29, 2020 (HealthDay News) — Patients with apparent treatment-resistant hypertension are rarely tested for primary aldosteronism, according to a study published online Dec. 29 in the Annals of Internal Medicine. Jordana B. Cohen, M.D., from the University of Pennsylvania in Philadelphia, and colleagues examined the testing rate for primary aldosteronism and evidence-based hypertension...